FDAnews Device Daily Bulletin
March 16, 2005 | Vol. 2 No. 53
Conor Medsystems, a developer of controlled vascular drug delivery technologies, has signed an agreement with Novartis Pharma granting Conor the right to evaluate three Novartis pharmaceutical compounds for the potential development of a product combining a Novartis compound with Conor's reservoir-based drug-eluting stents for the treatment of vascular diseases.
A Delaware jury has ruled that Medtronic violated stent patents held by Johnson & Johnson's Cordis unit.
The FDA has approved Boston Scientific's Quincy Distribution Center as a sterilization site for its Cutting Balloon microsurgical dilatation device product line, the company said.
Advanced Neuromodulation Systems has received FDA approval to market and sell its second rechargeable implantable pulse generator (IPG), the Eon Neurostimulation System.
Meridian received FDA approval for its low-level laser therapy device, the Lapex-2000.
Orthovita, a developer of synthetic biomaterials for the orthopedic market, announced that it has been granted a U.S. patent covering the development and use of composite shaped bodies for a range of applications in orthopedic surgery.
Natus Medical announced the signing of a private label agreement with Fisher & Paykel, a manufacturer of neonatal warmers, resuscitators and respiratory care devices.
NeuroMetrix, a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, announced that it has joined Eli Lilly in an Education & Development Program to improve awareness and detection of diabetic peripheral neuropathy.
Siemens Medical Solutions said it would increase its presence in China and aim to make the country its second-largest market after the U.S.
Grant Life Sciences (GLS) has secured rights to technology for rapid testing of AIDS and Dengue Fever, the company said.
Dj Orthopedics, a global medical device company specializing in rehabilitation and regeneration products for the non-operative orthopedic and spine markets, announced the acquisition of substantially all of the assets of Superior Medical Equipment (SME) for approximately $3.7 million, plus additional payments based on achievement of certain operating targets.
Curatronic announced that it has obtained FDA marketing approval for the Biomove 3000 Stroke Rehabilitation system.
Endocare, a medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation along with vacuum technologies for erectile dysfunction, reported that it has completed a private placement of 5,635,378 newly issued shares of its common stock raising approximately $15.6 million in gross proceeds.
LifePoint, a provider of noninvasive drug diagnostic technologies and solutions, announced the hiring of Gerry Braun as the company's new chief financial officer, effective immediately.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.